Amato D, Mendoza L, Gallardo Y, Santos D
Departamento de Nefrología, Hospital de Pediatría, Centro Médico Nacional, Siglo XXI, México, D.F.
Bol Med Hosp Infant Mex. 1991 Jul;48(7):484-9.
In order to evaluate the usefulness of certain clinical and paraclinical characteristics to be able to discriminate the minimal change disease (MCD) from other histopathological lesions associated with the nephrotic syndrome (NS), the clinical charts of 31 patients were reviewed and relevant data were analyzed. Those patients with no history of biopsy and those with documented MCD through biopsy, were placed in one group (MCD = 25) and the rest as others (others = 6). None of the clinical or paraclinical indicators analyzed showed significant differences between either group. In the MCD group, 76% of the patients entered remission after receiving steroid treatment, while none of the others entered remission. The magnitude of the proteinuria, hypoalbuminemia, hypercholesterolemia, and the presence of hematuria, hypertension or hyperazoemia, were not useful to discriminate those with MCD from other lesions. The response to treatment with prednisone was the most useful data to differentiate the groups.
为了评估某些临床和临床旁特征对于鉴别微小病变病(MCD)与其他与肾病综合征(NS)相关的组织病理学病变的有用性,回顾了31例患者的临床病历并分析了相关数据。将那些没有活检病史以及通过活检确诊为MCD的患者归为一组(MCD = 25),其余患者归为另一组(其他 = 6)。所分析的临床或临床旁指标在两组之间均未显示出显著差异。在MCD组中,76%的患者在接受类固醇治疗后进入缓解期,而其他组患者均未进入缓解期。蛋白尿、低白蛋白血症、高胆固醇血症的程度以及血尿、高血压或高氮质血症的存在,对于鉴别MCD患者与其他病变患者并无帮助。对泼尼松治疗的反应是区分两组的最有用数据。